Soluble receptors and cytokine antagonists in human milk

Pediatric Research

Volumn 40, Issue 6, 1996, Pages 839-844

  Buescher, E Stephen ^a,b   Malinowska, Iwona ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b CENTER FOR PEDIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6 RECEPTOR; RECEPTOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST FEEDING; BREAST MILK; CELL ADHESION; COLOSTRUM; CONTROLLED STUDY; FOOD COMPOSITION; HUMAN; INFLAMMATION; PRIORITY JOURNAL;

EID: 0029846458     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199612000-00011     Document Type: Article

References (45)

1. Goldman AS, Thorpe LW, Goldblum RM, Hanson LA 1986 Anti-inflammatory properties of human milk. Acta Paediatr Scand 75:689-695
2. Goldman AS, Goldblum RM, Hanson LA 1990 Anti-inflammatory systems in human milk. Adv Exp Med Biol 262:69-76
3. Goldman AS 1993 The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J 12:664-672
4. Buescher ES, McIlheran SM 1988 Antioxidant properties of human colostrum. Pediatr Res 24:14-19
5. Buescher ES, McIlheran SM, French RW 1989 Further characterization of human colostral antioxidants: identification of an ascorbate-like element as an anti-oxidant component and demonstration of anti-oxidant heterogeneity. Pediatr Res 25:266-270
6. Buescher ES, McIlheran SM 1993 Polymorphonuclear leukocytes and human colostrum: effects of in vivo and in vitro exposure. J Pediatr Gastroenterol Nutr 17:424-433
7. Thorpe LW, Rudloff HE, Powell LC, Goldman A 1986 Decreased response of human milk leukocytes to chemoattractant peptides. Pediatr Res 20:373-377
8. Mandalapu P, Pabst HF, Paetkau V 1995 A novel immunosuppressive factor in human colostrum. Cell Immunol 162:178-184.
9. Newburg DS, Viscidi RP, Ruff A, Yolken RH 1992 A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor. Pediatr Res 31:22-28
10. Rudloff EH, Schmalsteig FC, Mushtaha AA, Palkowetz KH, Liu SK, GOldman AS 1992 Tumor necrosis factor-α in human milk. Pediatr Res 31:29-33
11. Garofalo R, Chheda S, Mei F, Palkowetz KH, Rudloff HE, Schmalsteig FC, Rassin DK, Goldman AS 1995 Interleukin-10 in human milk. Pediatr Res 37:444-449
12. Newburg DS, Ashkenazi S, Cleary TG 1992 Human milk contains the shiga toxin and shiga-like toxin receptor glycolipid Gb3. J Infect Dis 166:832-836
13. Newburg DS, Pickering LK, McCluer RH, Cleary TG 1990 Fucosylated oligosaccharides of human milk protect suckling mice from heat stable enterotoxin of Escherichia coli. J Infect Dis 162:1075-1080
14. Emödy L, Carlsson A, Ljungh A, Wadström T 1988 Mannose-resistant haemagglutination by Campylobacter pylori. Scand J Infect Dis 20:353-354
15. Kunz C, Rudloff S 1993 Biological functions of oligosaccharides in human milk. Acta Paediatr 82:903-912
16. Murphey DK, Buescher ES 1993 Human colostrum has anti-inflammatory activity in rat subcutaneous air pouch model of inflammation. Pediatr Res 34:208-212
17. Bishai D, Bishai M 1987 Gonococcal ophthalmia neonatorum. N Engl J Med 316:1549
18. Dinarello CA, Gelfand JA, Wolff SM 1993 Anticytokine strategies in the treatment of systemic inflammatory response syndrome JAMA 269:1829-1835
19. Arai K, Lee F, Myajima A, Miyatake S, Arai N, Yokata T 1990 Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783-836
20. Rozdzinski E, Jones T, Bumette WJ, Burroughs M, Tuomanen E 1993 Antiinflammatory effects in experimental meningitis of prokaryotic peptides that mimic selectins. J Infect Dis 168:1422-1428
21. Thomas TK, Will PC, Srivastava A, Wilson CL, Harbison M, Little J, Chesonis RS, Pignatello M, Schmolze D, Symington J, Kilian PL, Thompson RC 1991 Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model. Agents Actions 34:187-190
22. Martin D, Near SL, Bendele A, Russell DA 1995 Inhibition of tumor necrosis factor is protective against neurologic dysfunction after activ immunization of Lewis rats with myelin basic protein. Exp Neurol 131:221-228
23. Hartung T, Döcke W-D, Gantner F, Krieger G, Sauer A, Stevens P, Volk H-D, Wendel A 1995 Effect of granulocyte colony stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482-2489
24. Engelberts I, Stephens S, Francot GJM, van der Linden CJ, Buurman WA 1991 Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338:515-516
25. Pickering LK, Morrow AL, Herrera I, O'Ryan M, Estes MK, Guillams SE, Jackson L, Carter-Campbell S, Matson DO 1995 Effect of maternal rotavirus immunization on milk and serum antibody titers. J Infect Dis 172:723-728
26. Pall AA, Adu D, Drayson M, Taylor CM, Richards NT, Michael J 1994 Circulating soluble adhesion molecules in systemic vasculitis. Nephrol Dial Transplant 9:770-774
27. Wenisch C, Varijanonta S, Looareesuwan S, Grainger W, Pichler R 1994 Soluble intercellular adhesion molecule-1 (ICAM-1), endothelial leukocyte adhesion molecule-1 (ELAM-1) and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 71:334-348
28. Spronk PE, Bootsma H, Huitma MG, Limburg PC, Kallenberg CG 1994 Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosis (SLE); a long term prospective study. Clin Exp Immunol 97:439-444
29. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL 1994 Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 79:707-711
30. Gabay C, Gay-Crosier F, Roux-Lombard P, Meyer O, Maineti C, Guerne PA, Vischer T, Dayer JM 1994 Elevated levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum 37:1744-1751
31. Gaillard JP, Bataille R, Brailly H, Zuber C, Yasukawa K, Altal M, Maruo N, Taga T, Kishimoto T, Klein B 1993 Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23:820-824
32. Mitsuyama K, Toyonga A, Sasaki E, Ishida O, Ikelda H, Tsuruta O, Harada K, Tateishi H, Nishiyama T, Tanikawa K 1995 Soluble interleukin-6 Gut 36:45-49
33. Seckinger P, Isaaz S. Dayer M 1989 Purification and biologic characterization of a specific tumor necrosis factor inhibitor. J Biol Chem 264:11966-11973
34. Engelmann H, Novick DN, Wallach D 1989 Two tumor necrosis factor binding proteins from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531-1536
35. Dinarello CA, Wolff SM 1993 The role of interleukin-1 in disease. N Engl J Med 328:106-113
36. Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russel DA 1995 Multifunctional regulation of the biological effects of TNF-α by the soluble type I and II receptors. Cytokine 7:26-38
37. Pforte A, Schiessler A, Gais P, von Kress S, Beer B, Riethmuller G, Ziegler-Heitbrock HW 1993 Expression of the adhesion molecule ICAM-1 on alveolar machrophanges and in serum in extrinsic allergic alveolitis. Respiration 60:221-226
38. Gearing AJH, Memingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ 1992 Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 67:324-331
39. Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, Peterson M 1995 Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37:55-62
40. Janssen BA, Luqmani RA, Gordon C, Hemingway IH, Bacon PA, Gearing AJ, Emery P 1994 Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 33:1112-1116
41. Boehme MW, Werle E, Kommerell B, Raeth U 1994 Serum levels of adhesion molecules and thrombomodulin as indicators of vascular injury in severe Plasmodium falciparum malaria. Clin Invest 72:598-603
42. Kuhns DB, Alvord WG, Gallin JI 1995 Increased circulating cytokines, cytokine antagonists and E-selectin after intravenous administration of endotoxin to humans. J Infect Dis 171:145-152
43. Dinarello CA 1991 Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652
44. Müllberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S 1993 The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 223:473-480
45. Pennica D, Kohr WJ, Fendly BM, Shire SJ, Raab HE, Borchardt PE, Lewis M, Goeddel DV 1992 Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-α induced receptor aggregation. Biochemistry 31:1134-1141